Cargando…

Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases

BACKGROUND: To investigate the clinical efficacy and safety of bone cement combined with radiofrequency ablation (RFA) in the treatment of spinal metastases. METHODS: The medical records of patients with spinal metastatic tumor admitted to our hospital from January 2016 to December 2018 were retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Nanning, Geng, Rui, Ling, Feng, Zhou, Zhangzhe, Liu, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672858/
https://www.ncbi.nlm.nih.gov/pubmed/33208129
http://dx.doi.org/10.1186/s12883-020-01998-5
_version_ 1783611219517636608
author Lv, Nanning
Geng, Rui
Ling, Feng
Zhou, Zhangzhe
Liu, Mingming
author_facet Lv, Nanning
Geng, Rui
Ling, Feng
Zhou, Zhangzhe
Liu, Mingming
author_sort Lv, Nanning
collection PubMed
description BACKGROUND: To investigate the clinical efficacy and safety of bone cement combined with radiofrequency ablation (RFA) in the treatment of spinal metastases. METHODS: The medical records of patients with spinal metastatic tumor admitted to our hospital from January 2016 to December 2018 were retrospectively analyzed. Based on different surgical methods, the patients were divided into groups A (treated with RFA combined with bone cement) and B (treated with bone cement only). Group A included 35 patients with 47 segments of diseased vertebral bodies. Group B consisted of 52 patients with 78 vertebral segments. Pain, quality of life score, vertebra height, bone cement leakage, postoperative tumor recurrence, and complications were assessed 3 days and 1 and 6 months after surgery. RESULTS: All the patients had smooth operation without paraplegia, spinal cord injury, and perioperative death. Visual analogue scales (VAS) and Oswestry Disability Index (ODI) scores of the two groups significantly improved 3 days and 1 month after surgery compared with those before surgery (P < 0.05), but no significant difference was observed between the two groups (P > 0.05). Six months after surgery, the VAS and ODI scores of patients in group A were lower than those in group B, with statistically significant differences (P < 0.05). The postoperative vertebral body height of the two groups significantly increased compared with that before surgery, and the difference was statistically significant (P < 0.05). Meanwhile, no significant difference was observed between the two groups (P > 0.05). Postoperative bone cement permeability in group A was 6.4%, and postoperative tumor recurrence rate was 11.4%. The permeability of bone cement in group B was 20.5%, and the tumor recurrence rate was 30.8%. The bone cement permeability and tumor recurrence rate in group A were lower than those in group B, with statistically significant differences (P < 0.05). CONCLUSIONS: Bone cement combined with RFA for the treatment of spinal metastases can achieve good efficacy, desirable analgesic effect, low incidence of complications, small surgical trauma, and high safety. The proposed method has the value of clinical popularization and application.
format Online
Article
Text
id pubmed-7672858
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76728582020-11-19 Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases Lv, Nanning Geng, Rui Ling, Feng Zhou, Zhangzhe Liu, Mingming BMC Neurol Technical Advance BACKGROUND: To investigate the clinical efficacy and safety of bone cement combined with radiofrequency ablation (RFA) in the treatment of spinal metastases. METHODS: The medical records of patients with spinal metastatic tumor admitted to our hospital from January 2016 to December 2018 were retrospectively analyzed. Based on different surgical methods, the patients were divided into groups A (treated with RFA combined with bone cement) and B (treated with bone cement only). Group A included 35 patients with 47 segments of diseased vertebral bodies. Group B consisted of 52 patients with 78 vertebral segments. Pain, quality of life score, vertebra height, bone cement leakage, postoperative tumor recurrence, and complications were assessed 3 days and 1 and 6 months after surgery. RESULTS: All the patients had smooth operation without paraplegia, spinal cord injury, and perioperative death. Visual analogue scales (VAS) and Oswestry Disability Index (ODI) scores of the two groups significantly improved 3 days and 1 month after surgery compared with those before surgery (P < 0.05), but no significant difference was observed between the two groups (P > 0.05). Six months after surgery, the VAS and ODI scores of patients in group A were lower than those in group B, with statistically significant differences (P < 0.05). The postoperative vertebral body height of the two groups significantly increased compared with that before surgery, and the difference was statistically significant (P < 0.05). Meanwhile, no significant difference was observed between the two groups (P > 0.05). Postoperative bone cement permeability in group A was 6.4%, and postoperative tumor recurrence rate was 11.4%. The permeability of bone cement in group B was 20.5%, and the tumor recurrence rate was 30.8%. The bone cement permeability and tumor recurrence rate in group A were lower than those in group B, with statistically significant differences (P < 0.05). CONCLUSIONS: Bone cement combined with RFA for the treatment of spinal metastases can achieve good efficacy, desirable analgesic effect, low incidence of complications, small surgical trauma, and high safety. The proposed method has the value of clinical popularization and application. BioMed Central 2020-11-18 /pmc/articles/PMC7672858/ /pubmed/33208129 http://dx.doi.org/10.1186/s12883-020-01998-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Technical Advance
Lv, Nanning
Geng, Rui
Ling, Feng
Zhou, Zhangzhe
Liu, Mingming
Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title_full Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title_fullStr Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title_full_unstemmed Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title_short Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
title_sort clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672858/
https://www.ncbi.nlm.nih.gov/pubmed/33208129
http://dx.doi.org/10.1186/s12883-020-01998-5
work_keys_str_mv AT lvnanning clinicalefficacyandsafetyofbonecementcombinedwithradiofrequencyablationinthetreatmentofspinalmetastases
AT gengrui clinicalefficacyandsafetyofbonecementcombinedwithradiofrequencyablationinthetreatmentofspinalmetastases
AT lingfeng clinicalefficacyandsafetyofbonecementcombinedwithradiofrequencyablationinthetreatmentofspinalmetastases
AT zhouzhangzhe clinicalefficacyandsafetyofbonecementcombinedwithradiofrequencyablationinthetreatmentofspinalmetastases
AT liumingming clinicalefficacyandsafetyofbonecementcombinedwithradiofrequencyablationinthetreatmentofspinalmetastases